Skip to content

Comparing Midazolam, Ketamine, and Dexmedetomidine as Sedation Options for Children Undergoing Radiology Scans

Comparison of midazolam, ketamine and dexmedetomidine as premedications for radiological imaging in children under 10 years of age - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090838
Enrollment
81
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G408- Other epilepsy and recurrent seizures

Interventions

Intervention1: sedative drugs such as midazolam, ketamine, dexmedetomidine: Children undergoing radiological investigations are given intravenous sedative agents to prevent anxiety during imaging Cont

Sponsors

DR REXINA DARTHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children under 18 years of age requiring sedative agents for investigation purposes

Exclusion criteria

Exclusion criteria: Patients requiring mechanical ventilation and intravenous inotropic support and those with cyanotic CHD, second- and third-degree heart. Children with muscular dystrophies, multiple congenital anomalies, hepatic or renal dysfunction, and allergy to any of the used drugs were excluded.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the effect of sedation by dexmedetomidine, midazolam, ketamine in a group of children.Timepoint: To evaluate and compare the effect of sedation by dexmedetomidine, midazolam, ketamine in a group of children under 10 years of age , for a period of 24 hours post sedations

Secondary

MeasureTime frame
TO COMPARE THE EFFECTS OF KETAMINE, MIDAZOLAM, DEXMEDETOMIDINE ON THE DURATION OF SEDATIONTimepoint: TO COMPARE THE EFFECTS OF KETAMINE, MIDAZOLAM, DEXMEDETOMIDINE ON THE DURATION OF SEDATION AND ADVERSE EVENTS THAT OCCUR WITHIN 24 HOURS AFTER SEDATION

Countries

India

Contacts

Public ContactDR JAISHREE

CHETTINA HOSPITAL AND RESEARCH INSTITUTE

vsdvnjshr@gmail.com9444362134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026